Primary care engagement is associated with increased pharmacotherapy prescribing for alcohol use disorder (AUD)
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1940-0640
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Primary care engagement is associated with increased pharmacotherapy prescribing for alcohol use disorder (AUD) ; volume:14 ; number:1 ; day:1 ; month:5 ; year:2019 ; pages:1-7 ; date:12.2019
Addiction science & clinical practice ; 14, Heft 1 (1.5.2019), 1-7, 12.2019
- Urheber
-
Joudrey, Paul J.
Kladney, Mat
Cunningham, Chinazo O.
Bachhuber, Marcus A.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s13722-019-0147-3
- URN
-
urn:nbn:de:101:1-2019051319131539178406
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:50 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Joudrey, Paul J.
- Kladney, Mat
- Cunningham, Chinazo O.
- Bachhuber, Marcus A.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Endpoints for Pharmacotherapy Trials for Alcohol Use Disorder
Prescribing Pharmacotherapy for Major Depressive Disorder: How Does a Clinician Decide?
Pharmacotherapy for alcohol use disorder among adults with medical disorders in Sweden
Quadruple pharmacotherapy for alcohol use disorder tolerable yet insufficient: a case report
Medication underuse in older outpatients : a pharmacoepidemiological approach towards an optimized pharmacotherapy using explicit prescribing criteria
Pharmacotherapy in glaucoma
Pharmacotherapy of obesity
Pharmacotherapy for Nocturia
From pharmaco-therapy to pharmaco-prevention: trends in prescribing to older adults in Ontario, Canada, 1997-2006
How useful are prescribing indicators based on the DU90% method to distinguish the quality of prescribing between pharmacotherapy audit meetings with different levels of functioning?
Involvement of Fibroblast Growth Factor 2 (FGF-2) in Alcohol Use Disorder (AUD)
Rhinitis: immunopathology and pharmacotherapy
Endpoints for Pharmacotherapy Trials for Alcohol Use Disorder
Prescribing Pharmacotherapy for Major Depressive Disorder: How Does a Clinician Decide?
Pharmacotherapy for alcohol use disorder among adults with medical disorders in Sweden
Quadruple pharmacotherapy for alcohol use disorder tolerable yet insufficient: a case report
Medication underuse in older outpatients : a pharmacoepidemiological approach towards an optimized pharmacotherapy using explicit prescribing criteria
Pharmacotherapy in glaucoma
Pharmacotherapy of obesity
Pharmacotherapy for Nocturia
From pharmaco-therapy to pharmaco-prevention: trends in prescribing to older adults in Ontario, Canada, 1997-2006
How useful are prescribing indicators based on the DU90% method to distinguish the quality of prescribing between pharmacotherapy audit meetings with different levels of functioning?
Involvement of Fibroblast Growth Factor 2 (FGF-2) in Alcohol Use Disorder (AUD)
Rhinitis: immunopathology and pharmacotherapy
Endpoints for Pharmacotherapy Trials for Alcohol Use Disorder
Prescribing Pharmacotherapy for Major Depressive Disorder: How Does a Clinician Decide?
Pharmacotherapy for alcohol use disorder among adults with medical disorders in Sweden
Quadruple pharmacotherapy for alcohol use disorder tolerable yet insufficient: a case report
Medication underuse in older outpatients : a pharmacoepidemiological approach towards an optimized pharmacotherapy using explicit prescribing criteria
Pharmacotherapy in glaucoma
Pharmacotherapy of obesity
Pharmacotherapy for Nocturia
From pharmaco-therapy to pharmaco-prevention: trends in prescribing to older adults in Ontario, Canada, 1997-2006
How useful are prescribing indicators based on the DU90% method to distinguish the quality of prescribing between pharmacotherapy audit meetings with different levels of functioning?
Involvement of Fibroblast Growth Factor 2 (FGF-2) in Alcohol Use Disorder (AUD)